Published in Oncotarget on July 21, 2017
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
The ubiquitin system. Annu Rev Biochem (1998) 43.36
New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst (1990) 23.46
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med (2006) 10.48
The ubiquitin code. Annu Rev Biochem (2012) 7.08
A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature (2006) 5.57
Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cell (2013) 3.43
Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science (2005) 3.22
Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol (2005) 2.73
Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J Cell Biol (2007) 2.53
Evidence for a repair enzyme complex involving ERCC1 and complementing activities of ERCC4, ERCC11 and xeroderma pigmentosum group F. EMBO J (1993) 2.45
Autophagosomes: biogenesis from scratch? Curr Opin Cell Biol (2005) 2.42
Autoregulation of an E2 enzyme by ubiquitin-chain assembly on its catalytic residue. Nat Cell Biol (2007) 2.32
Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J Cell Sci (1983) 2.26
Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro. EMBO J (1993) 2.04
Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res (2009) 2.03
X-ray and biochemical anatomy of an archaeal XPF/Rad1/Mus81 family nuclease: similarity between its endonuclease domain and restriction enzymes. Structure (2003) 2.03
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer. Chest (2005) 1.93
Peptide therapeutics: current status and future directions. Drug Discov Today (2014) 1.83
The structure of the human ERCC1/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair. Structure (2005) 1.80
Constructing and decoding unconventional ubiquitin chains. Nat Struct Mol Biol (2011) 1.76
Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1. Proc Natl Acad Sci U S A (2005) 1.54
Mutational analysis of the human nucleotide excision repair gene ERCC1. Nucleic Acids Res (1996) 1.53
Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. Nature (2016) 1.52
Proteasome system of protein degradation and processing. Biochemistry (Mosc) (2009) 1.35
A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling. Mol Cell (2009) 1.31
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. DNA Repair (Amst) (2010) 1.30
Mapping of interaction domains between human repair proteins ERCC1 and XPF. Nucleic Acids Res (1998) 1.28
ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel. BMC Cancer (2008) 1.24
DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy. Nucleic Acids Res (2012) 1.22
The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis. Lung Cancer (2010) 1.19
Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination. Cancer Res (2010) 1.11
Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance. Oncogene (2011) 1.01
Regulating the 26S proteasome. Curr Top Microbiol Immunol (2002) 0.97
Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction. PLoS One (2012) 0.92
ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br J Cancer (2013) 0.89
Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum. Gynecol Oncol (2012) 0.86
Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex. J Biol Chem (2005) 0.85
mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines. Respirology (2008) 0.84
USP45 deubiquitylase controls ERCC1-XPF endonuclease-mediated DNA damage responses. EMBO J (2014) 0.84
Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study. Gynecol Oncol (2012) 0.83
Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach. J Mol Graph Model (2009) 0.82
Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease. Cell Rep (2016) 0.82
Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance. DNA Repair (Amst) (2015) 0.81
Identification of DNA repair gene Ercc1 as a novel target in melanoma. Pigment Cell Melanoma Res (2011) 0.81
Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells. Mol Pharmacol (2013) 0.81
ERCC1 mRNA levels can predict the response to cisplatin-based concurrent chemoradiotherapy of locally advanced cervical squamous cell carcinoma. Radiat Oncol (2012) 0.81
Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF. Bioorg Med Chem Lett (2015) 0.79
Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability. Clin Exp Pharmacol Physiol (2014) 0.78
Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells. Oncotarget (2016) 0.78
N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF. Bioorg Med Chem Lett (2015) 0.77
New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy. J Mol Graph Model (2016) 0.77